Chemicals and pharmaceuticals · GOSS

Gossamer Bio, Inc.

3 filings mentioning 4 of the compliance and risk topics we track, most recently 2026-07-15. Every row links to the filing on EDGAR.

Updated

3filings we hold
4topics disclosed
Chemicals and pharmaceuticalsindustry
CAbased in

What it discloses

Tracked topics appearing in this company's filings, most frequent first. Each opens the topic, where you can see who else files it and what it obligates.

TopicFilingsMost recent
Restatement32026-07-15
Consent Order12026-06-05
Enforcement Action12026-06-05
Regulatory Investigation12026-05-18

Recent filings

FiledFormItem
2026-07-158-KDirector or officer departure, Item 5.03, Shareholder votefiling
2026-06-058-KEntry into a material agreement, Item 1.02, Item 2.03filing
2026-05-188-KEntry into a material agreement, Results of operations, the earnings release, Director or officer departurefiling

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down, in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All companies · Today's edition